Infant, Newborn – Talk Bio

Rallybio Halts Development of Lead FNAIT Program Following Phase 2 Failure

2 weeks ago talkbio0Tagged Alloimmune thrombocytopenia, Biotech pipeline shift, Fetal and neonatal alloimmune thrombocytopenia, Fetus, immune disorder therapy, Infant, Newborn, Mother (person), Phase 2 clinical trial, Rallybio RLYB212

Rallybio RLYB212, Fetal and neonatal alloimmune thrombocytopenia (FNAIT), Phase 2 clinical trial, Maternal immune disorder therapy, Biotech pipeline shift

FDA Urges Enhanced Authority to Combat Pediatric and Neonatal Medical Device Shortages

3 months ago talkbio0Tagged Authority, Infant, Newborn, Medical Device Shortages, Pediatric brand name, regulatory, Supply Chain Vulnerabilities, United States Food and Drug Administration

FDA, Medical Device Shortages, Pediatric Patients, Neonatal Patients, Supply Chain Vulnerabilities, Regulatory Authority

Duchenne Muscular Dystrophy: Potential Inclusion in Newborn Screening Programs

12 months ago talkbio0Tagged Decision Making, Diagnosis, Infant, Newborn, medical experts, Muscular Dystrophy, Duchenne

Duchenne muscular dystrophy, newborn screening, medical experts, decision-making, early diagnosis, treatment options.